AgelessRx Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Ann Arbor MI United States (2019)

Organization Overview

First Clinical Trial
2020
NCT04488601
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

AgelessRx